CSBR
Champions Oncology Records Strong Operational Performance in Q3 2026
Champions Oncology, a leading translational oncology services company, has announced strong operational performance in its third quarter fiscal year 2026 earnings call. The company delivered another quarter of record services revenue, underscoring the strength of its core translational oncology services platform and the resilience of customer relationships. According to Rob